Dr. Galsky on the Rationale for the CheckMate-274 Trial in Urothelial Cancer

Press/Media

Period	8 Mar 2023

Media coverage

Title	Dr. Galsky on the Rationale for the CheckMate-274 Trial in Urothelial Cancer
Media name/outlet	OncLive
Country/Territory	United States
Date	8/03/23
URL	ct.moreover.com/?a=50198869755&p=1gw&v=1&x=IKAdRCgiTlNlgWc2a0wPLQ
Persons	Matthew Galsky